Statistics
Publications
1
Citations
194
H-Index
1
Active since
2017
Affiliations
Glycomine, Inc. (United States)(Current)
Yi-Chang Liu is an author at Glycomine, Inc. (United States) specializing in proteasome-mediated degradation, molecular oncology, and proteasome inhibitor therapy.
Publications per year
2017–2017
1
1